denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), MPN, Chronic Myeloid Malignancies, Diseases, Myeloid Malignancies, Technology and Procedures, Measurable Residual Disease , Molecular testing
Session: MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), MPN, Chronic Myeloid Malignancies, Diseases, Myeloid Malignancies, Technology and Procedures, Measurable Residual Disease , Molecular testing
Sunday, December 8, 2024, 9:30 AM-10:45 AM
Disclosures: Mead: Ionis: Consultancy, Honoraria; Medscape: Honoraria; GSK: Consultancy, Honoraria, Research Funding; Karyopharm: Consultancy, Honoraria; Morphosys: Consultancy, Honoraria; Abbvie: Consultancy, Honoraria; BMS: Consultancy, Honoraria, Research Funding; Novartis: Consultancy, Honoraria, Research Funding; Alethiomics: Consultancy, Current equity holder in private company, Current holder of stock options in a privately-held company, Research Funding; Incyte: Consultancy, Honoraria; Galecto: Consultancy, Honoraria, Research Funding; Pfizer: Consultancy, Honoraria; Roche: Research Funding.
See more of: MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
See more of: Education Program
See more of: Education Program
Previous Presentation
|
Next Presentation >>